Hanly et al. (Hanly et al., 2021) analysed 56 CHD2 gene mutations through a literature search and found that 80.3% (45 cases) of the patients had epilepsy; the incidence of epilepsy in our study was 87.5%. This evidence concerns the gene CHD2 and epilepsy.